A Study of Volociximab in Metastatic Melanoma

Summary

This is a Phase 2, multicenter, research study determining the effects of an investigational drug called volociximab in metastatic melanoma. The purpose of the study is to compare the clinical benefit and safety of volociximab. Pharmacokinetics and mechanism of action will also be evaluated.

Timeline

Start

2006-12

Primary completion

2008-03

Completion

2008-03

Outcome

Outcome not reported

Stopped: “Insufficient clinical activity”

Drugs

Indications